An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.


Symptoms and diagnosis

Symptoms:

    


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.